Additionally, the staining intensity of FAP and DAB2 also exhibited a significant positive correlation with tumor size and patient serum AFP concentration (Spearman correlation analysis, P < 0.0001), suggesting their potential as indicators of tumor progression in clinical practice (Figure 7D). This evidence concerns the gene DAB2 and neoplasm.